Stat launched today. NiemanLab reports that while the site, which has 50 employees (compared to just 6 for Crux), is providing content to the Globe and is covering Kendall Square and the Longwood Medical Area, it's not limiting itself to local coverage - and could sign content deals with other media outlets.
City IT workers have begun mapping out existing underground conduits to see if there's enough room for another company - or the city itself - to lay the cables needed to bring competitive high-speed broadband to Boston, City Councilor Matt O'Malley (Jamaica Plain, West Roxbury) said today. Read more.
City officials today announced a new program, called BoSTEM, to provide all BPS middle-school students with science, technology, engineering and math by 2020: Read more.
The city's IT department is advertising for a Broadband and Digital Equity Advocate. Read more.
The Dana-Farber Cancer Institute is suing a Japanese researcher it says patented a promising method for battling cancer that is based on work by researchers at Dana-Farber and Genetics Institute in Cambridge. A Japanese drug company and Bristol-Myers Squibb are also named. Read more.
Councilor Charles Yancey (Dorchester) today proposed installing WiFi systems in BHA senior and family housing buildings to provide free Internet access to residents.
Yancey said Internet access is vital in today's world, but that residents of housing projects often cannot afford to connect.
Several years ago, then Councilor John Tobin proposed a citywide WiFi network. Mayor Menino Wified the idea, which ultimately went nowhere.
Councilor Tito Jackson praised Yancey's idea as "a no brainer."
Children's Hospital is suing a researcher who left the hospital last year, charging he took potentially valuable data related to the development of new drugs when he left for Vanderbilt University in Nashville. Read more.
City Councilor Matt O'Malley (Jamaica Plain, West Roxbury) today proposed a property-tax exemption for residents who convert their homes to solar power. Read more.
The Boston Business Journal reports on the sensor, intended to be implanted during a biopsy. A key issue: How to get power to the thing. Magnets to the rescue.
The Boston Stress Study hopes to outfit large numbers of Bostonians with wearable stress monitors so that it can come up with accurate numbers on just how crazed life is in this never-say-stop 21st-century city - and how that breaks down across professions, locations and, who knows, maybe even T lines.
WBUR's CommonHealth has more on the study, an effort by local startup Neumitra, which, you'll not be surprised to learn, hopes to sell "embedded biomodules to accurately and continuously measure the autonomic nervous system throughout daily life demands."
The Boston Business Journal reports the homegrown insurer has gotten FAA approval to use drones to survey houses and businesses damaged by fires or other disasters rather than sending out adjusters.
N. Anthony Coles, who recently returned to head up a biotech startup (based on work at MIT, natch), writes about the area's emergence as the world's leading innovation center in the field:
It has become an almost utopian community, where intellect knows no bounds, and science always trumps difficult disease treatment problems, cracking code after code to derive new state-of-the-art therapies with space-age technologies.
WBUR reports on work at Northeastern to deal with the fact that Lyme Disease often doesn't seem to completely die off after treatment with antibiotics: Researchers are looking at how to kill off the "persister" spores that can erupt back into infection after a patient is given a regular course of the drugs - by adding additional courses of medication over a period of time.
The Boston Business Journal reports a Boston startup is getting ready to ship wristbands that you can use to give your self an electric shock every time you're about to do something you shouldn't - such as smoke a cigarette.
Pavlok's eponymous device can be set to supply as little as a "pinprick" or as much as 450 volts of searing electropain. The Journal reports interest is particularly strong among Norwegians, Brits and Germans.